Skip to main content
Erschienen in: Cancer Causes & Control 8/2012

01.08.2012 | Original paper

Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study

verfasst von: Mieke Van Hemelrijck, Ruben Hermans, Karl Michaelsson, Jennifer Melvin, Hans Garmo, Niklas Hammar, Ingmar Jungner, Göran Walldius, Lars Holmberg

Erschienen in: Cancer Causes & Control | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Observational studies have shown a positive association between intake of dairy products as well as serum levels of calcium and prostate cancer (PCa) risk. We studied the association between serum calcium and PCa while also accounting for levels of albumin, a protein to which calcium is bound.

Methods

A cohort based on 196,022 men with baseline information on calcium (mmol/L) and albumin (g/L) was selected from the Swedish Apolipoprotein MOrtality RISk study. Age-stratified multivariable Cox proportional hazard models were used to analyze associations between calcium and incident and fatal PCa risk.

Results

A total of 6,353 men were diagnosed with PCa and 731 died of PCa during mean follow-up of 12 years. A weak negative association was found between levels of calcium or albumin-corrected calcium and PCa risk (HR for quartiles of albumin-corrected calcium: 0.95 (0.89–1.02), 0.93 (0.86–1.00), and 0.91 (0.85–0.98) for the 2nd, 3rd, and 4th quartile compared to the 1st; p for trend: 0.012). BMI did not affect these findings. No association was found between calcium levels and fatal PCa. A positive association between Ca and death was observed when censoring for PCa [HR per SD: 1.14 (1.13–1.16)].

Conclusion

The weak negative association between Ca and PCa risk is likely explained by the relation between Ca and death. This illustrates the need to handle competing risks when defining whether Ca is involved in PCa etiology or whether it acts as a marker of other metabolic events in the causal pathway.
Literatur
1.
Zurück zum Zitat Chan JM, Giovannucci EL (2001) Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiol Rev 23(1):87–92PubMedCrossRef Chan JM, Giovannucci EL (2001) Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiol Rev 23(1):87–92PubMedCrossRef
2.
Zurück zum Zitat Butler LM, Wong AS, Koh WP, Wang R, Yuan JM, Yu MC (2010) Calcium intake increases risk of prostate cancer among Singapore Chinese. Cancer Res 70(12):4941–4948PubMedCrossRef Butler LM, Wong AS, Koh WP, Wang R, Yuan JM, Yu MC (2010) Calcium intake increases risk of prostate cancer among Singapore Chinese. Cancer Res 70(12):4941–4948PubMedCrossRef
3.
Zurück zum Zitat Halthur C, Johansson AL, Almquist M, Malm J, Gronberg H, Manjer J et al (2009) Serum calcium and the risk of prostate cancer. Cancer Causes Control 20(7):1205–1214PubMedCrossRef Halthur C, Johansson AL, Almquist M, Malm J, Gronberg H, Manjer J et al (2009) Serum calcium and the risk of prostate cancer. Cancer Causes Control 20(7):1205–1214PubMedCrossRef
4.
Zurück zum Zitat Skinner HG, Schwartz GG (2008) Serum calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 17(9):2302–2305PubMedCrossRef Skinner HG, Schwartz GG (2008) Serum calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 17(9):2302–2305PubMedCrossRef
5.
Zurück zum Zitat Skinner HG, Schwartz GG (2009) The relation of serum parathyroid hormone and serum calcium to serum levels of prostate-specific antigen: a population-based study. Cancer Epidemiol Biomarkers Prev 18(11):2869–2873PubMedCrossRef Skinner HG, Schwartz GG (2009) The relation of serum parathyroid hormone and serum calcium to serum levels of prostate-specific antigen: a population-based study. Cancer Epidemiol Biomarkers Prev 18(11):2869–2873PubMedCrossRef
6.
Zurück zum Zitat Skinner HG, Schwartz GG (2009) A prospective study of total and ionized serum calcium and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 18(2):575–578PubMedCrossRef Skinner HG, Schwartz GG (2009) A prospective study of total and ionized serum calcium and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 18(2):575–578PubMedCrossRef
7.
Zurück zum Zitat Schwartz GG (2009) Is serum calcium a biomarker of fatal prostate cancer? Future Oncol 5(5):577–580PubMedCrossRef Schwartz GG (2009) Is serum calcium a biomarker of fatal prostate cancer? Future Oncol 5(5):577–580PubMedCrossRef
8.
Zurück zum Zitat Bringhurst F, Demay M, Krane S, Kronenberg H (2008) Bone and mineral metabolism in health and disease. In: Fauci A, Longo D, Kasper D, Braunwald E, Jameson J, Loscalzo J et al (eds) Harrrion’s Prinicples of Internal Medicine. McGraw-Hill, New York Bringhurst F, Demay M, Krane S, Kronenberg H (2008) Bone and mineral metabolism in health and disease. In: Fauci A, Longo D, Kasper D, Braunwald E, Jameson J, Loscalzo J et al (eds) Harrrion’s Prinicples of Internal Medicine. McGraw-Hill, New York
9.
Zurück zum Zitat Jungner I, Marcovina SM, Walldius G, Holme I, Kolar W, Steiner E (1998) Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials. Clin Chem 44(8 Pt 1):1641–1649PubMed Jungner I, Marcovina SM, Walldius G, Holme I, Kolar W, Steiner E (1998) Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials. Clin Chem 44(8 Pt 1):1641–1649PubMed
10.
Zurück zum Zitat Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E (2001) High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358(9298):2026–2033PubMedCrossRef Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E (2001) High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358(9298):2026–2033PubMedCrossRef
11.
Zurück zum Zitat Holme I, Aastveit AH, Jungner I, Walldius G (2008) Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 264(1):30–38PubMedCrossRef Holme I, Aastveit AH, Jungner I, Walldius G (2008) Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 264(1):30–38PubMedCrossRef
12.
Zurück zum Zitat Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2009) Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 265(2):275–287PubMedCrossRef Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2009) Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 265(2):275–287PubMedCrossRef
13.
Zurück zum Zitat Walldius G, Jungner I, Kolar W, Holme I, Steiner E (1992) High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study. Blood Press Suppl 4:35–42PubMed Walldius G, Jungner I, Kolar W, Holme I, Steiner E (1992) High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study. Blood Press Suppl 4:35–42PubMed
14.
Zurück zum Zitat Van Hemelrijck M, Garmo H, Binda E, Hayday A, Karagiannis SN, Hammar N et al (2010) Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study. Cancer Causes Control 9(21):1657–1667CrossRef Van Hemelrijck M, Garmo H, Binda E, Hayday A, Karagiannis SN, Hammar N et al (2010) Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study. Cancer Causes Control 9(21):1657–1667CrossRef
15.
Zurück zum Zitat Van Hemelrijck M, Garmo H, Holmberg L, Walldius G, Jungner I, Hammar, N Lambe M (2010) Prostate cancer risk in the Swedish AMORIS study: the interplay among triglycerides, total cholesterol, and glucose. Cancer 117(10):2086–2095 Van Hemelrijck M, Garmo H, Holmberg L, Walldius G, Jungner I, Hammar, N Lambe M (2010) Prostate cancer risk in the Swedish AMORIS study: the interplay among triglycerides, total cholesterol, and glucose. Cancer 117(10):2086–2095
17.
Zurück zum Zitat Akre O, Garmo H, Adolfsson J, Lambe M, Bratt O, Stattin P (2011) Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden. Eur Urol 60(3):554–563PubMedCrossRef Akre O, Garmo H, Adolfsson J, Lambe M, Bratt O, Stattin P (2011) Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden. Eur Urol 60(3):554–563PubMedCrossRef
18.
Zurück zum Zitat Pintilie M (2006) Competing risks: a practical perspective. Willey, West Sussex Pintilie M (2006) Competing risks: a practical perspective. Willey, West Sussex
19.
Zurück zum Zitat Grundmark B, Garmo H, Loda M, Busch C, Holmberg L, Zethelius B (2010) The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes. Cancer Epidemiol Biomarkers Prev 19(8):2088–2096PubMedCrossRef Grundmark B, Garmo H, Loda M, Busch C, Holmberg L, Zethelius B (2010) The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes. Cancer Epidemiol Biomarkers Prev 19(8):2088–2096PubMedCrossRef
20.
Zurück zum Zitat Pepe MS, Mori M (1993) Kaplan–Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 12(8):737–751PubMedCrossRef Pepe MS, Mori M (1993) Kaplan–Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 12(8):737–751PubMedCrossRef
21.
Zurück zum Zitat Oury F, Sumara G, Sumara O, Ferron M, Chang H, Smith CE et al (2011) Endocrine regulation of male fertility by the skeleton. Cell 144(5):796–809PubMedCrossRef Oury F, Sumara G, Sumara O, Ferron M, Chang H, Smith CE et al (2011) Endocrine regulation of male fertility by the skeleton. Cell 144(5):796–809PubMedCrossRef
22.
23.
Zurück zum Zitat Huggins C, Hodges CV (1972) Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin 22(4):232–240PubMedCrossRef Huggins C, Hodges CV (1972) Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin 22(4):232–240PubMedCrossRef
24.
Zurück zum Zitat Richter E, Srivastava S, Dobi A (2007) Androgen receptor and prostate cancer. Prostate Cancer Prostatic Dis 10(2):114–118PubMedCrossRef Richter E, Srivastava S, Dobi A (2007) Androgen receptor and prostate cancer. Prostate Cancer Prostatic Dis 10(2):114–118PubMedCrossRef
25.
Zurück zum Zitat Berry PA, Birnie R, Droop AP, Maitland NJ, Collins AT (2011) The calcium sensor STIM1 is regulated by androgens in prostate stromal cells. Prostate 71(15):1646–1655 Berry PA, Birnie R, Droop AP, Maitland NJ, Collins AT (2011) The calcium sensor STIM1 is regulated by androgens in prostate stromal cells. Prostate 71(15):1646–1655
26.
Zurück zum Zitat Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A et al (2011) Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 26(6):1948–1955PubMedCrossRef Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A et al (2011) Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 26(6):1948–1955PubMedCrossRef
27.
Zurück zum Zitat Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ et al (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305(11):1119–1127PubMedCrossRef Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ et al (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305(11):1119–1127PubMedCrossRef
28.
Zurück zum Zitat Holzmann M, Jungner I, Walldius G, Ivert I, Nordqvist T, Östergren J (2008) Apolipoproteins B and A-I, standard lipid measures and incidence of myocardial infarction in men and women, with or without chronic kidney disease. Study IV in Thesis for doctorial degree (PhD). In: Holzmann M (ed) Renal insufficiency, mortality and myocardial infarction. Karolinska Institutet, Stockholm Holzmann M, Jungner I, Walldius G, Ivert I, Nordqvist T, Östergren J (2008) Apolipoproteins B and A-I, standard lipid measures and incidence of myocardial infarction in men and women, with or without chronic kidney disease. Study IV in Thesis for doctorial degree (PhD). In: Holzmann M (ed) Renal insufficiency, mortality and myocardial infarction. Karolinska Institutet, Stockholm
29.
Zurück zum Zitat Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ 342:d2040PubMedCrossRef Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ 342:d2040PubMedCrossRef
Metadaten
Titel
Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study
verfasst von
Mieke Van Hemelrijck
Ruben Hermans
Karl Michaelsson
Jennifer Melvin
Hans Garmo
Niklas Hammar
Ingmar Jungner
Göran Walldius
Lars Holmberg
Publikationsdatum
01.08.2012
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 8/2012
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-0015-x

Weitere Artikel der Ausgabe 8/2012

Cancer Causes & Control 8/2012 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.